PPZ1-TORC1 Pathway Regulates Ferroptosis and Drug Resistance in C. albicans

Study Background and Research Question

Candida albicans is a prominent fungal pathogen implicated in a wide spectrum of infections, ranging from superficial oral candidiasis to life-threatening systemic disease, particularly in immunocompromised hosts. The rise of antifungal resistance, exacerbated by biofilm formation and limited drug classes, has intensified the search for novel therapeutic targets. Ferroptosis, a regulated cell death mechanism driven by iron-dependent lipid peroxidation, has been extensively characterized in mammalian systems, but its biological relevance and regulation in fungi remain poorly understood. The present study addresses whether ferroptosis operates as a distinct death program in C. albicans and explores the molecular determinants governing this process, particularly the role of the PPZ1-TORC1 pathway (reference study).

Key Innovation from the Reference Study

The study's central innovation lies in identifying a unique regulatory axis—PPZ1-TORC1—that modulates both ferroptosis sensitivity and antifungal drug resistance in C. albicans. Unlike mammalian ferroptosis, which depends on proteins such as GPX4, the fungal system relies on the fungus-specific serine/threonine phosphatase PPZ1 to govern downstream TORC1 signaling and ferroptotic susceptibility. The work is among the first to demonstrate that pharmacological induction of ferroptosis by tert-butyl hydroperoxide (t-BuOOH) in C. albicans leads to lethal accumulation of iron-dependent lipid peroxides, and that the PPZ1-TORC1 pathway is a pivotal modulator of this process. These findings suggest a previously unappreciated intersection between cell death regulation and antifungal resistance mechanisms.

Methods and Experimental Design Insights

The researchers utilized a multifaceted approach combining genetic, pharmacological, and biochemical assays. Wild-type and PPZ1-deleted (ppz1Δ) C. albicans strains were exposed to t-BuOOH to model lipophilic oxidant-induced ferroptosis. Lipid peroxidation was quantified using established fluorescent probes, while cell viability assays determined ferroptotic death. The study also assessed TORC1 pathway activity and autophagy induction through phospho-specific antibodies and autophagosome markers, respectively. Drug sensitivity profiles were generated by exposing strains to a panel of standard antifungal agents. This comprehensive design allowed for dissection of the PPZ1-TORC1 axis in both ferroptosis and antifungal resistance contexts.

Core Findings and Why They Matter

• Lipid Peroxidation Drives Fungal Ferroptosis: Exposure to t-BuOOH triggered significant accumulation of iron-dependent lipid peroxides, resulting in ferroptotic cell death in C. albicans.
• PPZ1 Modulates Ferroptosis Sensitivity: Deletion of PPZ1 heightened sensitivity to t-BuOOH-induced ferroptosis, suggesting that PPZ1 functions as a negative regulator of this pathway through modulation of TORC1 signaling.
• Cross-talk Between TORC1, Autophagy, and Ferroptosis: Impaired TORC1 activity in the ppz1Δ background led to increased autophagy and exacerbated ferroptotic cell death, providing a mechanistic link between these pathways.
• PPZ1-TORC1 Axis and Antifungal Resistance: The same pathway conferred resistance to multiple antifungal drugs; loss of PPZ1 reduced drug tolerance, indicating an interconnected regulatory network.

Collectively, these findings provide a novel mechanistic framework for targeting ferroptosis—via inhibition of lipid peroxidation or manipulation of the PPZ1-TORC1 axis—as an antifungal strategy. The evidence also establishes that pathways controlling cell death can influence drug resistance, opening new avenues for combination therapies.

Comparison with Existing Internal Articles

Most internal articles linked below focus on mammalian models of ferroptosis, inhibition of lipid peroxidation, and GPX4-deficient cell protection:

• Mechanistic Insights and Translational Advances with Liproxstatin-1—details how this potent ferroptosis inhibitor elucidates iron-dependent cell death pathways in mammalian systems, with emphasis on nanomolar efficacy and translational relevance.
• Potent Ferroptosis Inhibition in GPX4-Deficient Models—highlights Liproxstatin-1’s selective mechanism and its value in renal and hepatic injury models for studying ferroptosis research workflows.
• Translational Ferroptosis Research Beyond Lipid Peroxidation—places Liproxstatin-1 in the context of advanced research and protocol guidance, with a focus on mechanistic depth and workflow optimization.

Unlike these studies, the reference paper uniquely addresses fungal ferroptosis and introduces the PPZ1-TORC1 pathway as a regulatory node. Whereas mammalian paradigms often center on GPX4, C. albicans appears to have evolved distinct regulatory machinery, underscoring the need to adapt research tools and strategies when transitioning between biological kingdoms.

Limitations and Transferability

Several limitations should be noted. First, while the study convincingly demonstrates that t-BuOOH induces ferroptosis in C. albicans, it does not exhaustively explore other fungal species or clinical isolates, potentially limiting generalizability. Second, the absence of direct orthologs for mammalian ferroptosis regulators (e.g., GPX4) in fungi suggests that inhibitors optimized for mammalian systems may require adaptation for effective use in fungal models. Finally, in vivo relevance for antifungal therapy awaits validation, as the results are largely based on in vitro and ex vivo analyses.

Protocol Parameters

• Induction of ferroptosis: Treat C. albicans cultures with t-BuOOH at concentrations empirically determined to induce lipid peroxidation; optimize based on strain sensitivity and desired endpoint.
• Assessment of lipid peroxidation: Use fluorescent probes such as BODIPY 581/591 C11 to quantify peroxidized lipids in fungal cells.
• Genetic manipulation: Employ CRISPR-mediated gene knockout or RNAi to delete or downregulate PPZ1 or TORC1 components for mechanistic studies.
• Drug sensitivity testing: Expose wild-type and mutant strains to a panel of antifungal agents, measuring growth or viability as endpoints.
• Autophagy markers: Monitor autophagosome formation and TORC1 activity using phospho-specific antibodies and relevant fluorescent markers.

Research Support Resources

For researchers interested in probing ferroptosis mechanisms or screening inhibitors in non-mammalian models, Liproxstatin-1 (SKU B4987) is a well-characterized small molecule inhibitor of ferroptotic cell death. While the current reference paper focuses on fungal-specific pathways, Liproxstatin-1’s efficacy in blocking lipid peroxidation and its established use in GPX4-deficient and renal failure models (internal reference) make it a valuable benchmark for comparative ferroptosis research. APExBIO provides detailed technical specifications for Liproxstatin-1 to support rigorous experimental workflows.